Literatur
-
1
MacNee W.
Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part One.
Am J Respir Crit Care Med.
1994;
150
833-852 Review
-
2
Oswald-Mammosser M, Weitzenblum E, Quoix E, Moser G, Chaouat A, Charpentier C, Kessler R.
Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure.
Chest.
1995;
107
1193-1198
-
3
Chailleux E, Fauroux B, Binet F, Dautzenberg B, Polu J M.
Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. A 10-year analysis of ANTADIR Observatory.
Chest.
1996;
109
741-749
-
4
Dallari R, Barozzi G, Pinelli G, Merighi V, Grandi P, Manzotti M, Tartoni P L.
Predictors of survival in subjects with chronic obstructive pulmonary disease treated with long-term oxygen therapy.
Respiration.
1994;
61
8-13
-
5
Piccioni P, Caria E, Bignamini E, Forconi G, Nebiolo F, Arossa W, Bugiani M.
Predictors of survival in a group of patients with chronic airflow obstruction.
J Clin Epidemiol.
1998;
5
547-555
-
6
Weitzenblum E, Oswald M, Mirhom R, Kessler R, Apprill M.
Evolution of pulmonary haemodynamics in COLD patients under long-term oxygentherapy.
Eur Respir J Suppl.
1989;
7
669s-673s. Review
-
7
Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Hirth C, Roegel E.
Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease.
Am Rev Respir Dis.
1984;
130
993-998
-
8
Saadjian A Y, Philip-Joel F F, Barret A, Levy S, Arnaud A G.
Effect of almitrine bismesylate on pulmonary vasoreactivity to hypoxia in chronic obstructive pulmonary disease.
Eur Respir J.
1994;
7
862-868
-
9
Watanabe S, Kanner R E, Cutillo A G, Menlove R L, Bachand Jr R T, Szalkowski M B, Renzetti Jr A D.
Long-term effect of almitrine bismesylate in patients with hypoxemic chronic obstructive pulmonary disease.
Am Rev Respir Dis.
1989;
140
1269-1273
-
10
Winkelmann B R, Kullmer T H, Kneissl D G, Trenk D, Kronenberger H.
Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronicobstructive pulmonary disease.
Chest.
1994;
105
1383-1391
-
11
Nowak D, Wywiol A, Magnussen H.
Almitrin in der Therapie der chronisch obstruktiven Bronchitis mit Hypoxämie: Eine Multicenter Studie.
Pneumologie.
1998;
52
121-127
-
12
Adnot S, Samoyeau R, Weitzenblum E.
Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil.
Blood Press.
1995;
Suppl 3
47-57. Review
-
13
Agostoni P, Doria E, Galli C, Tamborini G, Guazzi M C.
Nifedipine reduces pulmonary pressure and vascular tone during short- but not long-term treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease.
Am Rev Respir Dis.
1989;
139
120-125
-
14
Archer S L, Mike D, Crow J, Long W, Weir E K.
A placebo-controlled trial of prostacyclin in acute respiratory failure in COPD.
Chest.
1996;
109
750-755
-
15
Domenighetti G M, Saglini V G.
Short- and long-term hemodynamic effects or oral nifedipine in patients with pulmonary hypertension secondary to COPD and lung fibrosis. Deleterious effects in patients with restrictive disease.
Chest.
1992;
102
708-714
-
16
Gassner A, Sommer G, Fridrich L, Magometschnigg D, Priol A.
Differential therapy with calcium antagonists in pulmonary hypertension secondary to COPD. Hemodynamic effects of nifedipine, diltiazem, and verapamil.
Chest.
1990;
98
829-834
-
17
Giaid A.
Nitric oxide and endothelin-1 in pulmonary hypertension.
Chest.
1998;
114
208S-212S
-
18
Lampert E, Tuo N, Frans A, Lonsdorfer J.
Disappearance of molsidomine effects on pulmonary circulation of patients with chronic obstructive pulmonary disease after a three week treatment.
Pathol Biol (Paris).
1991;
39
29-33
-
19
Peacock A.
Vasodilators in pulmonary hypertension.
Thorax.
1993;
48
1196-1199
-
20
Aida A, Miyamoto K, Nishimura M, Aiba M, Kira S, Kawakami Y.
Prognostic value of hypercapnia in patients with chronic respiratory failure during long-term oxygen therapy.
Am J Respir Crit Care Med.
1998;
158
188-193
-
21
Dubois P, Jamart J, Machiels J, Smeets F, Lulling J.
Prognostic of severely hypoxemic patients receiving long-term oxygen therapy.
Chest.
1994;
105
469-474
-
22
Ström K, Boman G.
Long-term oxygen therapy in parenchymal lung diseases: an analysis of survival. The Swedish Society of Chest Medicine.
Eur Respir J.
1993;
6
1264-1270
-
23
Veale D, Chailleux E, Taytard A, Cardinaud J P.
Characteristics and survival of patients prescribed long-term oxygen therapy outside prescription guidelines.
Eur Respir J.
1998;
12
780-784
-
24
Gorecka D, Gorzelak K, Sliwinski P, Tobiasz M, Zielinski J.
Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia.
Thorax.
1997;
52
674-679
-
25
Sliwinski P, Hawrylkiewicz I, Gorecka D, Zielinski J.
Acute effect of oxygen on pulmonary arterial pressure does not predict survival on long-term oxygen therapy in patients with chronic obstructive pulmonary disease.
Am Rev Respir Dis.
1992;
146
665-669
-
26
de Bruin P F, Ueki J, Bush A, Khan Y, Watson A, Pride N B.
Diaphragm thickness and inspiratory strength in patients with Duchenne muscular dystrophy.
Thorax.
1997;
52
472-475
-
27
de Bruin P F, Ueki J, Watson A, Pride N B.
Size and strength of the respiratory and quadriceps muscles in patients with chronic asthma.
Eur Respir J.
1997;
10
59-64
-
28
Kobayashi H, Sato T, Takada N, Tomita T.
Erythropoietin and base excess levels in patients with chronic pulmonary diseases.
Respir Physiol.
1997;
107
37-45
-
29
Polycythaemia due to hypoxaemia: advantage or disadvantage.
Lancet.
1989;
2 (8653)
20-22. Review
-
30
Palange P, Carlone S, Serra P, Mannix E T, Manfredi F, Farber M O.
Pharmacologic elevation of blood inorganic phosphate in hypoxemic patients with COPD.
Chest.
1991;
100
147-150
-
31
Timms R M, Tisi G M.
The effect of short-term oxygen supplementation on oxygen hemoglobin affinity in patients with chronic obstructive pulmonary disease.
Am Rev Respir Dis.
1985;
131
69-72
-
32
Bayanov A A, Brunt A R.
Role of hypoxia and constitutionally different resistance to hypoxia/stress as the determiners of individual profile of cytochrome P450 isozyme activity.
Gen Pharmacol.
1999;
33
355-361
-
33
Robin E D, Murphy B J, Theodore J.
Coordinate regulation of glycolysis by hypoxia in mammalian cells.
J Cell Physiol.
1984;
118
287-290
-
34
Simon L M, Robin E D, Phillips J R, Acevedo J, Axline S G, Theodore J.
Enzymatic basis for bioenergetic differences of alveolar versus peritoneal macrophages and enzyme regulation by molecular O2
.
J Clin Invest.
1977;
59
443-448
-
35
Cartee G D, Douen A G, Ramlal T, Klip A, Holloszy J O.
Stimulation of glucose transport in skeletal muscle by hypoxia.
J Appl Physiol.
1991;
70
1593-1600
-
36
Ouiddir A, Planes C, Fernandes I, VanHesse A, Clerici C.
Hypoxia upregulates activity and expression of the glucose transporter GLUT1 in alveolar epithelial cells.
Am J Respir Cell Mol Biol.
1999;
21
710-718
-
37
Fitting J W.
Respiratory muscle fatigue limiting physical exercise.
Eur Respir J.
1991;
4
103-108. Review
-
38
Johnson B D, Aaron E A, Babcock M A, Dempsey J A.
Respiratory muscle fatigue during exercise: implications for performance.
Med Sci Sports Exerc.
1996;
28
1129-1137. Review
-
39
Perret C, Pfeiffer R, Boutellier U, Wey H M, Spengler C M.
Noninvasive measurement of respiratory muscle performance after exhaustive endurance exercise.
Eur Respir J.
1999;
14
264-269
-
40
Ferguson G T, Irvin C G, Cherniack R M.
Relationship of diaphragm glycogen, lactate, and function to respiratory failure.
Am Rev Respir Dis.
1990;
141
926-932
-
41
Sahlin K, Tonkonogi M, Soderlund K.
Energy supply and muscle fatigue in humans.
Acta Physiol Scand.
1998;
162
261-266. Review
-
42
de OCA M M, Celli B R.
Respiratory muscle recruitment and exercise performance in eucapnic and hypercapnic severe chronic obstructive pulmonary disease.
Am J Respir Crit Care Med.
2000;
161
880-885
-
43
Jeffery Mador M, Kufel T J, Pineda L.
Quadriceps Fatigue after Cycle Exercise in Patients with Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med.
2000;
161
447-453
-
44
Rasche K, Laier-Groeneveld G, Weyland W, Braun U, Hüttemann U, Criee C P.
Sauerstoffverbrauch der Atemmuskulatur unter kontrollierter bzw. assistierter Beatmung bei Patienten mit chron. Ateminsuffizienz.
Med Klinik.
1994;
89
43-46
-
45
Mitrouska J, Xirouchaki N, Patakas D, Siafakas N, Georgopoulos D.
Effects of chemical feedback on respiratory motor and ventilatory output during different modes of assisted mechanical ventilation.
Eur Respir J.
1999;
13
873-882
-
46
Nava S, Ambrosino N, Bruschi C, Confalonieri M, Rampulla C.
Physiological effects of flow and pressure triggering during non-invasive mechanical ventilation in patients with chronic obstructive pulmonary disease.
Thorax.
1997;
52
249-254
-
47
Antonelli M, Conti G, Rocco M, Bufi M, DeBlasi R A, Vivino G, Gasparetto A, Meduri G U.
A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure.
N Engl J Med.
1998;
339
429-435
-
48
Brochard L, Mancebo J, Wysocki M, Lofaso F, Conti G, Rauss A, Simonneau G, Benito S, Gasparetto A, Lemaire F.
Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease.
N Engl J Med.
1995;
333
817-822
-
49
Nava S, Ambrosino N, Clini E, Prato M, Orlando G, Vitacca M, Brigada P, Fracchia C, Rubini F.
Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease. A randomized, controlled trial.
Ann Intern Med.
1998;
1; 128
721-728
-
50
Wysocki M, Tric L, Wolff M A, Gertner J, Millet H, Herman B.
Noninvasive pressure support ventilation in patients with acute respiratory failure.
Chest.
1993;
103
907-913
-
51
Aubier M, Murciano D, Milic-Emili J, Touaty E, Daghfous J, Pariente R, Derenne J P.
Effects of the administration of O2 on ventilation and blood gases in patients with chronic obstructive pulmonary disease during acute respiratory failure.
Am Rev Respir Dis.
1980;
122
747-754
-
52
Dunn W F, Nelson S B, Hubmayr R D.
Oxygen-induced hypercarbia in obstructive pulmonary disease.
Am Rev Respir Dis.
1991;
144
526-530
-
53
Begin P, Grassino A.
Inspiratory muscle dysfunction and chronic hypercapnia in chronic obstructive pulmonary disease.
Am Rev Respir Dis.
1991;
143
905-912
-
54
Chan C S, Grunstein R R, Bye P T, Woolcock A J, Sullivan C E.
Obstructive sleep apnea with severe chronic airflow limitation. Comparison of hypercapnic and eucapnic patients.
Am Rev Respir Dis.
1989;
140
1274-1278
-
55
Gorini M, Misuri G, Corrado A, Duranti R, Iandelli I, DePaola E, Scano G.
Breathing pattern and carbon dioxide retention in severe chronic obstructive pulmonary disease.
Thorax.
1996;
51
677-683
-
56
Ambrosino N.
Noninvasive mechanical ventilation in acute on chronic respiratory failure: determinants of success and failure.
Monaldi Arch Chest Dis.
1997;
52
73-75. Review
-
57
Plant P K, Elliott M W.
Non-invasive positive pressure ventilation.
J R Coll Physicians Lond.
199;
33
521-525. Review
-
58
Schönhofer B, Geibel M, Sonneborn M, Haidl P, Köhler D.
Daytime mechanical ventilation in chronic respiratory insufficiency.
Eur Respir J.
1997;
10
2840-2846
-
59
Schönhofer B, Sonneborn M, Haidl P, Böhrer H, Köhler D.
Comparison of two different modes for noninvasive mechanical ventilation in chronic respiratory failure: volume versus pressure controlled device.
Eur Respir J.
1997;
10
184-191
-
60
Schönhofer B, Ardes P, Geibel M, Köhler D, Jones P W.
Evaluation of a movement detector to measure daily activity in patients with chronic lung disease.
Eur Respir J.
1997;
10
2814-2819
-
61
Köhler D, Schönhofer B.
Apnoe-Hypopnoe. Eine oder zwei Entitäten.
Pneumologie.
1998;
52
311-318. Review
-
62
Schönhofer B, Köhler D.
Effect of non-invasive mechanical ventilation on sleep and nocturnal ventilation in patients with chronic respiratory failure.
Thorax.
2000;
55
308-313
1 Herrn Prof. Dr. med. Heinrich Matthys zum 65. Geburtstag gewidmet.
Prof. Dr D Köhler
Krankenhaus Kloster Grafschaft Zentrum für Pneumologie, Beatmungs- und Schlafmedizin
57392 Schmallenberg
